Search research articles
Contact Us
Filters
Showing results (11-20 of 277) with videos related to
Page
of 28
Sort By:
Clinical and Vaccine Immunology : CVI
|
July 3, 2015
Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea
Weiping Zhang, David A Sack
The Lancet. Global Health
|
August 15, 2018
Protection from killed oral cholera vaccine continues for 4 years
David A Sack, Mohammad Ali
The Indian Journal of Medical Research
|
December 10, 2016
The opportunities & challenges in delivering oral cholera vaccines
Jacqueline Deen, David A Sack
Expert Review of Vaccines
|
August 10, 2012
Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans
Weiping Zhang, David A Sack
Infection and Immunity
|
November 6, 2025
Recent progress in enterotoxigenic <i>Escherichia coli</i> vaccine research and development
Weiping Zhang, David A Sack
International Journal of Epidemiology
|
March 25, 2017
Integration of water, sanitation and hygiene intervention delivery at health facilities with a reactive ring vaccination programme to reduce cholera
Christine Marie George, David A Sack
Vaccine
|
December 2, 2014
Introducing cholera vaccination in Asia, Africa and Haiti: a meeting report
Robert H Hall, David A Sack
The Lancet. Global Health
|
February 23, 2015
Effectiveness of oral cholera vaccine in Haiti
Francisco J Luquero, David A Sack
Plos One
|
March 25, 2015
Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity
Xiaosai Ruan, David A Sack, Weiping Zhang
Vaccine
|
December 6, 2016
Ensuring access to oral cholera vaccine to those who need them most
Francisco J Luquero, Anne Ballard, David A Sack
Page
of 28
Search research articles
Search
Showing results (11-20 of 277) with videos related to
Sort By:
Page
of 28
Clinical and Vaccine Immunology : CVI
|
July 3, 2015
Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea
Weiping Zhang, David A Sack
The Lancet. Global Health
|
August 15, 2018
Protection from killed oral cholera vaccine continues for 4 years
David A Sack, Mohammad Ali
The Indian Journal of Medical Research
|
December 10, 2016
The opportunities & challenges in delivering oral cholera vaccines
Jacqueline Deen, David A Sack
Expert Review of Vaccines
|
August 10, 2012
Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans
Weiping Zhang, David A Sack
Infection and Immunity
|
November 6, 2025
Recent progress in enterotoxigenic <i>Escherichia coli</i> vaccine research and development
Weiping Zhang, David A Sack
International Journal of Epidemiology
|
March 25, 2017
Integration of water, sanitation and hygiene intervention delivery at health facilities with a reactive ring vaccination programme to reduce cholera
Christine Marie George, David A Sack
Vaccine
|
December 2, 2014
Introducing cholera vaccination in Asia, Africa and Haiti: a meeting report
Robert H Hall, David A Sack
The Lancet. Global Health
|
February 23, 2015
Effectiveness of oral cholera vaccine in Haiti
Francisco J Luquero, David A Sack
Plos One
|
March 25, 2015
Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity
Xiaosai Ruan, David A Sack, Weiping Zhang
Vaccine
|
December 6, 2016
Ensuring access to oral cholera vaccine to those who need them most
Francisco J Luquero, Anne Ballard, David A Sack
Page
of 28